Advanced search
Publication Cover
Renal Failure Volume 31, 2009 - Issue 2
Submit an article Journal homepage
2,329
Views
12
CrossRef citations to date
0
Altmetric
Clinical Studies

Effects of Immunosuppressive Drugs on Platelet Aggregation and Soluble P-Selectin Levels in Renal Transplant Patients

Garip Sahin Department of Nephrology, Eskisehir Osmangazi University Medical School, Eskisehir, TurkeyCorrespondence[email protected] [email protected]
,
Olga Meltem Akay Department of Hematology, Eskisehir Osmangazi University Medical School, Eskisehir, Turkey
,
Esin Kus Department of Hematology, Eskisehir Osmangazi University Medical School, Eskisehir, Turkey
,
Cengiz Bal Department of Biostatistics, Eskisehir Osmangazi University Medical School, Eskisehir, Turkey
,
Ahmet Ugur Yalcin Department of Nephrology, Eskisehir Osmangazi University Medical School, Eskisehir, Turkey
&
Zafer Gulbas Department of Hematology, Eskisehir Osmangazi University Medical School, Eskisehir, Turkey
Pages 111-117 | Received 25 Sep 2008, Accepted 04 Nov 2008, Published online: 07 Jul 2009

REFERENCES

  • Pham PT, Pham PC, Danovitch GM. Cardiovascular disease posttransplant. Semin Nephrol. 2007; 27(4)430–444
  • Sato K, Ogawa K, Onumata O, et al. Cause of death in renal transplant patients: A comparison between azathioprine and ciclosporin. Surg Today. 2001; 31: 681–687
  • Aker S, Ivens K, Grabensee B, Heering P. Cardiovascular risk factors and diseases after renal transplantation. Int Urol Nephrol. 1998; 30(4)777–788
  • Briggs JD. Causes of death after renal transplantation. Nephrol Dial Transplant. 2001; 16: 1545–1549
  • Ross R. The pathogenesis of atherosclerosis: An update. N Engl J Med. 1986; 314: 488–500
  • Vanrenterghem Y, Roels L, Lerut T, et al. Tromboembolic complications and haemostatic changes in cyclosporine-treated cadaveric kidney allograft recipients. Lancet. 1985; 1: 999–1002
  • Grace AA, Barradas MA, Mikhailidis DP, Jeremy JY, Sweny P, Dandona P. Cyclosporine A enhaces platelet aggregation. Kidney Int. 1987; 32(6)889–895
  • Malyszko J, Malyszko JS, Takada A, Mysliwiec M. Effects of immunosuppressive drugs platelet aggregation in vivo. Ann Transplant. 2002; 7(1)55–68
  • Graff J, Klinkhardt U, Harder S, et al. Immunosuppressive therapy regimen and platelet activation in renal transplant patients. Clin Pharmacol Ther. 2002; 72(4)411–418
  • Malyszko J, Malyszko JS, Pawlak K, Michal M. The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients. Transplantation. 1996; 62(2)828–830
  • Verpooten GA, Cools FJ, Van der Planken MG, et al. Elevated plasminogen activator inhibitor levels in cyclosporine-treated renal allograft recipients. Nephrol Dial Transplant. 1996; 11: 347–351
  • Opelz G, Wujciak T, Ritz E, et al. Association of chronic kidney graft failure with recipient blood pressure. Kidney Int. 1998; 53: 217–222
  • Canzanello VJ, Schwartz L, Tater SJ, et al. Evolution of cardiovascular risk after liver transplantation: A comparison of cyclosporine A and tacrolimus FK(506). Liver Transpl Surg. 1997; 3: 1–9
  • Grace AA, Barradas MA, Mikhailidis DP, et al. Cyclosporine A enhances platelet aggregation. Kidney Int. 1987; 32(6)889–895
  • Fernandes JB, Naik UP, Markell MS, Kornecki E. Comparative investigation of the effects of the immunusuppresants cyclosporine A, cyclosporine G, and FK-506 on platelet aggregation. Cell Mol Biol Res. 1993; 39(3)265–274
  • Klein BC, Bach D, Rehfeld I, et al. Influence of mycophenolic acid and FK-506 on human platelet activation in vitro. Kidney Blood Press Res. 2000; 23(2)119–124
  • Blann AD, Lip GY. Hypothesis: Is soluble P-selectin a new marker of platelet activation?. Atherosclerosis. 1997; 128: 135–138
  • Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD. Pro-coagulant state resulting from high levels of P-selectin in blood. Proc Natl Acad Sci USA. 2000; 97: 13835–13840
  • Blann AD, Fargher EB, McCollum CN. Increased soluble P-selecyn in ischaemic heart disease: A new marker for the progression of atherosclerosis. Blood Coagul Fibrinolys. 1997; 8: 383–390
  • Ridker PM, Buring JE, Rifai N. Soluble P-selectin and the risk of future cardiovascular events. Circulation. 2001; 103: 491–495
  • Hillis GS, Terregino C, Taggart P, Killian A, Zhao N, Dalsey WC. Elevated soluble P-selectin levels are associated with an increased risk of early adverse in patients with presumed myocardial infarction. Am Heart J. 2002; 143: 235–241

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.